↓ Skip to main content

Understanding the complex-I-ty of metformin action: limiting mitochondrial respiration to improve cancer therapy

Overview of attention for article published in BMC Biology, October 2014
Altmetric Badge

Mentioned by

twitter
6 X users
facebook
1 Facebook page

Citations

dimensions_citation
79 Dimensions

Readers on

mendeley
131 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Understanding the complex-I-ty of metformin action: limiting mitochondrial respiration to improve cancer therapy
Published in
BMC Biology, October 2014
DOI 10.1186/s12915-014-0082-4
Pubmed ID
Authors

Alba Luengo, Lucas B Sullivan, Matthew G Vander Heiden

Abstract

Metformin has been a first-line treatment for type II diabetes mellitus for decades and is the most widely prescribed antidiabetic drug. Retrospective studies have found that metformin treatment is associated with both reduced cancer diagnoses and cancer-related deaths. Despite the prevalence of metformin use in the clinic, its molecular mechanism of action remains controversial. In a recent issue of Cancer & Metabolism, Andrzejewski et al. present evidence that metformin acts directly on mitochondria to inhibit complex I and limits the ability of cancer cells to cope with energetic stress. Here, we discuss evidence that supports the role of metformin as a cancer therapeutic.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 131 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Chile 1 <1%
South Africa 1 <1%
Czechia 1 <1%
China 1 <1%
United States 1 <1%
Unknown 126 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 26 20%
Researcher 19 15%
Student > Master 18 14%
Student > Bachelor 15 11%
Student > Doctoral Student 6 5%
Other 20 15%
Unknown 27 21%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 32 24%
Medicine and Dentistry 29 22%
Agricultural and Biological Sciences 29 22%
Pharmacology, Toxicology and Pharmaceutical Science 6 5%
Environmental Science 2 2%
Other 7 5%
Unknown 26 20%